Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04443946Phase 4Completed
Phase 4, randomised, open-label trial of propofol, sevoflurane and sufentanil in general anesthesia (5 arms), sponsored by China International Neuroscience Institute. Primary endpoint: Extubation Duration up to 24 hours. Started Jun 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04443946.